M
Molecular Partners AG D
D
MOLN
3.98000
USD
0.06
(1.53%)
مغلق
حجم التداول
220
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
149,294,429
المقالات
العنوان: Molecular Partners AG
القطاع: Healthcare
الصناعة: Biotechnology
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPintherapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.